India Kidney Function Test Market By Test Type (Urine Test, Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests, Blood Test, Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests), By Component (Dipsticks, Reagents, Kits & Essays), By End User (Hospitals and Clinics, Diagnostics Laboratories, Academic and Research Institute), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Kidney Function Test Market was valued at USD 46.35 million in 2024 and is expected to reach USD 70.94 million by 2030 with a CAGR of 7.35% during the forecast period.

This can be ascribed to the increased awareness about kidney diseases, that how it is important to detect kidney diseases early and to raise awareness among the people regarding kidney diseases in India. There has been a significant increase in the prevalence of kidney diseases in India over the last few decades. This increase is mainly attributed to changes in lifestyle, including unhealthy diets, lack of physical activity, and an increase in the prevalence of diabetes and hypertension.

Patients are more informed about the benefits of early detection of kidney diseases, as a result, there is a growing need for early detection and management of kidney disease, which has led to an increase in demand for kidney function tests. These advancements have improved the accuracy and reliability of the tests, leading to greater acceptance of the tests by patients and healthcare professionals. Indian government has taken so many initiatives to improve healthcare in the country, including measures to increase access to kidney function tests.

For instance, the National Health Mission in India provides free diagnostic tests, including kidney function tests, to eligible individuals, which has helped to increase access to these tests. As the growing Indian economy has led to greater investments in healthcare infrastructure, including diagnostic labs and testing facilities, it has helped to fuel the growth of the India kidney function test market.

Key Market Drivers

Increasing Prevalence of Chronic Kidney Disease

• The rapidly increasing prevalence of chronic kidney disease serves as a massive driver for the India kidney function test market, because a significantly larger at-risk population directly elevates the pressing clinical need for early screening, accurate diagnosis, and continuous renal monitoring across both hospital and outpatient care settings.

• This escalating national health burden is being heavily intensified by the steady rise of diabetes, chronic hypertension, an aging demographic, and increasingly unhealthy lifestyle patterns, all of which are intrinsically linked to declining kidney function and directly drive higher demand for serum creatinine, urine albumin, and blood urea assessments.

• Because chronic kidney disease frequently progresses silently over many years without noticeable physical signs, routine preventative testing is absolutely essential for identifying microscopic organ damage long before highly vulnerable patients present with severe, debilitating symptoms that would inevitably require immensely costly medical interventions and specialized life-saving treatments.

• As modern healthcare systems place a much stronger clinical emphasis on risk-based screening for vulnerable demographic groups, diagnostic testing is becoming deeply embedded within national preventive care pathways, a massive clinical need highlighted by a 2025 systematic review revealing that Indian chronic kidney disease prevalence surged from 11.12% between 2011 and 2017 to a staggering 16.38% between 2018 and 2023.

Growing Awareness regarding Kidney Diseases

• The rapidly growing public awareness regarding complex kidney diseases is significantly strengthening the diagnostic testing market, as a much better understanding of silent disease progression and the critical importance of early diagnosis actively encourages millions of people to proactively seek preventive screening well before severe, irreversible kidney damage develops.

• This widespread societal awareness is steadily improving through a highly effective combination of targeted public health messaging, hospital-led diagnostic campaigns, localized physician outreach, dedicated patient advocacy groups, and condition-linked education specifically surrounding the dangerous renal impacts of diabetes and hypertension, which remain the primary contributors to kidney impairment in India.

• Heightened public health education directly benefits the medical testing market because this increased awareness not only drastically drives up initial first-time screening volumes but also significantly improves long-term patient follow-up behavior, encourages consistent repeat testing, and guarantees much more timely referrals into specialized nephrology care whenever abnormal renal markers are initially detected.

• As kidney disease becomes increasingly visible in mainstream healthcare communication, the market heavily benefits from a rapidly evolving preventive mindset that strongly supports the broader deployment of comprehensive renal panels across diagnostic camps, localized primary clinics, and routine corporate wellness checkups. This highly effective dynamic is perfectly illustrated by Ujala Cygnus Kulwanti Hospital and Noble Hospital successfully screening over 5,000 individuals during a massive month-long kidney health campaign in 2025.

Download Free Sample Report

Key Market Challenges

Limited Access to Healthcare in Rural Areas

• One of the primary challenges in the India kidney function test market is the limited access to healthcare, especially in rural and remote areas. Many regions in India lack adequate healthcare infrastructure, making it difficult for individuals to undergo routine kidney function tests like serum creatinine, blood urea nitrogen (BUN), and glomerular filtration rate (GFR).

• In rural areas, there is often a shortage of diagnostic centers equipped with advanced testing equipment and skilled healthcare personnel. This limits early detection and monitoring of kidney diseases, which are prevalent in India due to factors such as diabetes, hypertension, and high rates of chronic kidney disease (CKD). Overcoming this challenge requires significant investments in infrastructure, awareness campaigns, and mobile diagnostic solutions to ensure better access to kidney function tests for underserved populations.

High Cost of Advanced Diagnostic Technologies

• The high cost of advanced kidney function testing technologies is another major challenge in the market. Tests like GFR and molecular-based diagnostics can be expensive, particularly in the private healthcare sector, which limits accessibility for lower-income populations. Additionally, the need for specialized equipment and skilled technicians further increases the cost of these tests. This financial barrier often prevents timely detection and effective management of kidney diseases. While basic tests such as serum creatinine and BUN are more affordable, they may not provide a comprehensive understanding of kidney health. Making advanced kidney function tests more affordable and accessible is crucial to improving the overall management of kidney diseases in India.

Key Market Trends

Increasing Adoption of Point-of-Care POC Testing

• The rapidly increasing adoption of point-of-care (POC) testing is fundamentally emerging as a defining structural trend across the India kidney function test market by bringing crucial creatinine, urine, and renal risk assessments directly to the patient. This technological shift drastically reduces the historical dependence on centralized urban laboratories for critical first-line screening, ensuring that vital diagnostic information is captured swiftly and effectively exactly where the patient is initially treated.

• POC testing is incredibly relevant for India's massive rural and remote populations, who traditionally face severe diagnostic delays because immense travel times, restricted laboratory access, and incredibly complex follow-up barriers frequently slow testing for dangerous chronic kidney disease and acute kidney injury. Implementing portable diagnostic analyzers and near-patient testing formats successfully empowers clinicians to generate incredibly fast results, actively support crucial same-visit clinical decision-making, and successfully identify highly vulnerable individuals significantly earlier in their disease progression.

• As sophisticated POC tools become increasingly practical and cost-effective for localized primary care settings, highly mobile health units, and extensive outreach screening programs, they are drastically improving the geographic reach of vital kidney monitoring far beyond major urban hospitals, making timely medical interventions highly feasible for patients battling severe diabetes, chronic hypertension, or suspected early-stage kidney damage.

• The massive operational scalability and immense value of decentralized, near-patient diagnostics are beautifully demonstrated by a 2025 Indian study utilizing advanced point-of-care testing combined with seamlessly integrated digital health technology. This groundbreaking initiative successfully screened 843 highly vulnerable people in specific high-risk urban groups and 1,217 people living in rural CKDu hotspot areas across Andhra Pradesh, highlighting exactly how these portable systems actively reduce dangerous progression to advanced, end-stage renal disease.

Shift Toward Integrated and Comprehensive Kidney Health Monitoring Solutions

• The strategic shift toward highly integrated and incredibly comprehensive kidney health monitoring solutions is gaining massive momentum across India's clinical landscape as healthcare providers intentionally move far beyond relying solely on traditional stand-alone serum creatinine and basic blood urea nitrogen testing methodologies. Modern clinicians are actively transitioning toward highly sophisticated, multi-parameter assessments that successfully support significantly earlier disease detection, highly precise risk stratification, and continuous longitudinal management of complex renal conditions.

• This comprehensive clinical approach strategically combines crucial urine albumin, detailed creatinine levels, and specific albumin-to-creatinine ratio findings directly with deep patient histories, continuous diabetes and hypertension status tracking, and highly advanced digital follow-up tools. By thoroughly integrating these diverse data points, healthcare providers can meticulously identify critical signs of kidney stress and actively intervene long before severe renal decline becomes clinically obvious or entirely irreversible for the patient.

• Integrated digital diagnostic platforms are becoming increasingly relevant because the rising burden of chronic kidney disease across India is inextricably linked with the complex, ongoing management of various dangerous non-communicable diseases. This reality makes highly coordinated clinical screening and continuous patient monitoring drastically more useful and scientifically valuable than merely capturing isolated lab values taken at excessively long, highly disconnected intervals throughout the patient's care journey.

• The rapid nationwide expansion of sophisticated primary care diagnostics and fully digitally connected renal services is significantly strengthening the clinical case for comprehensive solutions that successfully combine precise testing, expert interpretation, and ongoing monitoring into one seamless care pathway. The massive scale of this expanding diagnostic infrastructure is powerfully reflected by government data showing that 1,82,944 Ayushman Arogya Mandirs were successfully operationalized by December 31, 2025, offering 63 critical diagnostics at PHC-level centers and 14 diagnostics at SHC-level centers across the country.

Segmental Insights

Component Insights

Based on component, the dipsticks category is currently dominating the India Kidney Function Test market due to their affordability, ease of use, and efficiency in providing rapid results. Dipsticks, also known as urine test strips, are widely used for initial screening and monitoring of kidney function. They are designed to detect a range of parameters such as protein, glucose, pH, specific gravity, and the presence of other substances like blood or ketones in urine, which are indicative of kidney health.

One of the key factors driving the dominance of dipsticks in the market is their low cost, making them accessible for widespread use, especially in resource-constrained settings and rural areas. These test strips provide quick results, making them ideal for point-of-care (POC) testing, where immediate feedback is needed for timely diagnosis and treatment. Dipsticks are commonly used in outpatient clinics, diagnostic centers, and even at home for routine monitoring of kidney function, particularly in individuals with risk factors such as diabetes, hypertension, or a family history of kidney disease.

Moreover, the simplicity of using dipsticks, requiring minimal training for healthcare providers and patients, contributes to their popularity. This ease of use is vital in improving early detection and continuous monitoring of kidney conditions, helping reduce the burden of chronic kidney disease (CKD) and acute kidney injury (AKI) in India. As healthcare accessibility improves and awareness about kidney health grows, the dipstick category is expected to maintain its dominance in the kidney function test market, especially for routine and preliminary screening purposes.

Download Free Sample Report

Regional Insights

Based on the region, East India was dominating in India Kidney Function Test Market in 2024, driven by the increasing prevalence of kidney diseases, particularly chronic kidney disease (CKD), and the growing demand for diagnostic services. States like West Bengal, Odisha, Bihar, Jharkhand, and Assam have seen rising rates of conditions such as diabetes and hypertension, which are major risk factors for kidney disease. The high incidence of these diseases in the region has significantly contributed to the demand for kidney function tests like serum creatinine, blood urea nitrogen (BUN), and urine tests.

The region's dominance can also be attributed to several healthcare developments. East India is witnessing improvements in healthcare infrastructure, with diagnostic centers, hospitals, and clinics expanding to meet the growing need for kidney function testing. The adoption of cost-effective and accessible diagnostic tools, such as dipsticks for initial screening and point-of-care (POC) devices, is further driving the growth in the region. Additionally, mobile health units and government-led initiatives aimed at improving healthcare access are ensuring that even underserved areas can benefit from these diagnostic services.

Recent Developments

• In February 2026, the Technology Development Board under the Department of Science and Technology signed an agreement with Prantae Solutions of Odisha to support manufacturing and commercialization of Proflo-U, an indigenous point-of-care renal diagnostic platform for kidney health assessment. The official release said Proflo-U includes urine albumin and urine creatinine measurement kits plus a portable analyzer that combines absorbance and fluorescence technologies, and is Bluetooth-, IoT-, and AI/ML-enabled through a linked mobile application. The platform was positioned as a breakthrough for India because it is designed to bring laboratory-grade biomarker testing for albumin, creatinine, and ACR closer to primary health centres and other last-mile settings.

• In April 2026, The Times of India reported that Andhra Pradesh had initiated biomarker-based testing for the first time to tackle the long-running kidney disease crisis in the Uddanam region. The report said a state-of-the-art laboratory had been established at King George Hospital in Visakhapatnam, that around 1,500 blood and urine samples had already been collected, and that urine-based biomarker testing was being used to identify people likely to develop kidney disease over the next three to four years. This is a notable innovation in India’s kidney-testing landscape because it shifts screening from conventional late-stage detection toward predictive risk assessment in a high-burden population.

• In April 2025, a study published in Kidney International Reports showed that point-of-care testing combined with integrated digital health technology successfully enabled screening for chronic kidney disease in high-risk populations in India. The publication concluded that POCT plus digital tools allowed diagnosis of CKD in high-risk groups and should be scaled up to support earlier diagnosis, lower costs, and better clinical management. Although this was reported through the scientific literature rather than a corporate press release, it represents a clear breakthrough innovation directly relevant to kidney function testing in India.

• In March 2025, Aagam Shree Foundation and Must & More Super Speciality Diagnostic Centre in Rohini announced a joint kidney-health screening initiative around World Kidney Day, offering free kidney function testing along with related diagnostics. The article said the collaboration was intended to raise awareness of kidney disease and encourage early detection by making essential tests such as KFT, CBC, and thyroid profile available without charge to participants. This qualifies as a collaboration-led development in India’s kidney function test ecosystem because it linked a foundation and a diagnostics provider to expand access to routine renal screening.

Key Market Players

• Abbott India Ltd
• Roche Diagnostics India Pvt. Ltd
• Siemens Healthineers India
• Bio-Rad Laboratories (India) Pvt. Ltd
• Inbios India
• NeoDocs
• Cosmetic Scientific Technologies

Report Scope:

In this report, the India Kidney Function Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Kidney Function Test Market, By Test Type:

o   Urine Test

o   Urine Protein Tests

o   Creatinine Clearance Tests

o   Microalbumin Tests

o   Blood Test

o   Serum Creatinine Tests

o   Glomerular Filtration Rate Tests

o   Blood Urea Nitrogen Tests

• India Kidney Function Test Market, By Component:

o   Dipsticks

o   Reagents

o   Kits & Essays

• India Kidney Function Test Market, By End User:

o   Hospitals and Clinics

o   Diagnostics Laboratories

o   Academic and Research Institute

• India Kidney Function Test Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Kidney Function Test Market.

Available Customizations:

India Kidney Function Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Kidney Function Test Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]